(redirected from Sequence Scanning)
Also found in: Medical, Encyclopedia.


 (sē′kwəns, -kwĕns′)
1. A following of one thing after another; succession.
2. An order of succession; an arrangement.
3. A related or continuous series. See Synonyms at series.
4. Games Three or more playing cards in consecutive order and usually the same suit; a run.
5. A series of related shots that constitute a complete unit of action in a movie.
6. Music A melodic or harmonic pattern successively repeated at different pitches with or without a key change.
7. Roman Catholic Church A hymn sung between the gradual and the Gospel.
8. Mathematics An ordered set of quantities, as x, 2x2, 3x3, 4x4.
9. Biochemistry The order of constituents in a polymer, especially the order of nucleotides in a nucleic acid or of the amino acids in a protein.
tr.v. se·quenced, se·quenc·ing, se·quenc·es
1. To organize or arrange in a sequence.
2. To determine the order of constituents in (a polymer, such as a nucleic acid or protein molecule).

[Middle English, a type of hymn, from Old French, from Medieval Latin sequentia, hymn, that which follows (from its following the alleluia), from Late Latin, from Latin sequēns, sequent-, present participle of sequī, to follow; see sekw- in Indo-European roots.]


1. (Biochemistry) the procedure of determining the order of amino acids in the polypeptide chain of a protein (protein sequencing) or of nucleotides in a DNA section comprising a gene (gene sequencing)
2. (Commerce) commerce Also called: priority sequencing specifying the order in which jobs are to be processed, based on the allocation of priorities


(ˈsi kwən sɪŋ)
the interruption of a career by a woman to bear and care for children until they reach an age that allows her to resume work.


[ˈsiːkwənsɪŋ] nséquençage m gene sequencing
References in periodicals archive ?
The Resolution System is the first commercial application of PathoGenetix's proprietary genome sequence scanning technology.
Results of sequence scanning have to be evaluated, prioritised and documented on a periodical basis.
In the present study, we developed and evaluated a modified base excision sequence scanning (BESS) protocol (7) for the detection of MLH1 and MSH2 germline mutations.
As PathoGenetix prepares to launch its Genome Sequence Scanning technology, we are fortunate to have a critical partner in its commercialization located in our own backyard.

Full browser ?